In Vitro Neurotoxicity Testing

Division ofBiosciences, University of Hertfordshire, College Lane, Hatfield, Herts. ALJO 9AB, UK; 4Institute of Toxicology, ETH and University of Zurich, Schorenstrasse 16, 8603 Schwerzenbach, Switzerland; NeuroSearch, 26B Smedeland, DK 2600 Glostrup, Denmark; Departamento de Zoologia, Universidade de Coimbra, 3059 Coimbra, Portugal; /n Vitro Neurotoxicology, The Wellcome Research Laboratories, Beckenham, Kent BR3 3BS, UK; BIBRA Toxicology International, Woodmansterne Road, Carshalton, Surrey SMS 4DS, UK; Institute of Environmental Medicine, Division of Toxicology, Karolinska Institute, Box 210, S-171 77 Stockholm, Sweden; Department of Pharmacology, University College Dublin, Dublin 4, Ireland; 11Department of Pharmacology and Toxicology, Consejo Superior de Investigaciones Cientificas, c!Jorge Girona Salgado 18-26, E-08034 Barcelona, Spain; CTL Pathology Department, Zeneca Pharmaceuticals, Alderley Park, Macclesfield, Cheshire SKlO 4TG, UK; 13Anatomy Department, University of Glasgow, Glasgow G12 8QQ, UK; 1US EPA, Health Effects Research Laboratory, Neurotoxicology Division, Research Triangle Park, NC 27711, USA; 15RITOX, Utrecht University, P.O. Box 80.176, 3508 TD Utrecht, The Netherlands; Pharmacia AB, Bioscience Center, S-112 87 Stockholm, Sweden; National Pharmaceutical Biotechnology Centre, Trinity College, Dublin 2, Ireland

[1]  Michael Balls,et al.  Animals and Alternatives in Toxicity Testing , 1985 .

[2]  C. Atterwill.  Brain Reaggregate Cultures in Neurotoxicological Investigations: Studies with Cholinergic Neurotoxins , 1989 .

[3]  D. Ray,et al.  Alternative Methods and Their Application in Neurotoxicity Testing , 1991 .

[4]  J. O'Callaghan,et al.  Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity. , 1992, Neurotoxicology.

[5]  B. Veronesi,et al.  In vitro screening batteries for neurotoxicants. , 1992, Neurotoxicology.

[6]  S. M. Thomas,et al.  New models for the In vitro assessment of neurotoxicity in the nervous system and the preliminary validation stages of a 'tiered-test' model. , 1993, Toxicology in vitro : an international journal published in association with BIBRA.

[7]  E. Walum,et al.  Cellular methods for identification of neurotoxic chemicals and estimation of neurotoxicological risk. , 1993, Toxicology in vitro : an international journal published in association with BIBRA.

[8]  S P Williams,et al.  Phase 1 of an in vitro neurotoxicological pre-validation trial. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  V. Pentreath,et al.  Alterations in the glial fibrillary acidic protein content of primary astrocyte cultures for evaluation of glial cell toxicity. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  W. Purcell,et al.  Human Placental Mast Cells as an In Vitro Model System in Aspects of Neuro-Immunotoxicity Testing , 1994, Human & experimental toxicology.